These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 697904)

  • 1. Release of endogenous catecholamines from isolated rat brain tissue by fenfluramine and N-ethylamphetamine--effects of pargyline.
    Tessel RE; Burgess SK; Rutledge CO
    Biochem Pharmacol; 1978; 27(12):1631-6. PubMed ID: 697904
    [No Abstract]   [Full Text] [Related]  

  • 2. The accumulation of p-hydroxyamphetamine by brain homogenates and its role in the release of catecholamines.
    Cho AK; Fischer JF; Schaeffer JC
    Biochem Pharmacol; 1977 Aug; 26(15):1367-72. PubMed ID: 901551
    [No Abstract]   [Full Text] [Related]  

  • 3. The mechanism of tetrahydroaminoacridine-evoked release of endogenous 5-hydroxytryptamine and dopamine from rat brain tissue prisms.
    Robinson TN; De Souza RJ; Cross AJ; Green AR
    Br J Pharmacol; 1989 Dec; 98(4):1127-36. PubMed ID: 2611486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of release of biogenic amines from isolated rat brain tissue as a function of the meta substituent of N-ethylamphetamine derivatives.
    Tessel RE; Rutledge CO
    J Pharmacol Exp Ther; 1976 May; 197(2):253-62. PubMed ID: 1271279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the effects of fenfluramine and amphetamine on uptake release and catabolism of norepinephrine in rat brain.
    Ziance RJ; Rutledge CO
    J Pharmacol Exp Ther; 1972 Jan; 180(1):118-26. PubMed ID: 5010409
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of amphetamines on the metabolism of catecholamines in the rat brain.
    Baldessarini RJ; Harris JE
    J Psychiatr Res; 1974; 11():41-3. PubMed ID: 4477777
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of repeated D-lysergic acid diethylamide injections on catecholamine levels and tyrosine hydroxylase activity in rat brain regions.
    Peters DA; Tang S
    J Neurochem; 1977 Jan; 28(1):59-62. PubMed ID: 13158
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of monoamine oxidase in determining the amount of monoamines released by drugs in the central nervous system.
    Rutledge CO; Azzaro AJ; Ziance RJ
    Adv Biochem Psychopharmacol; 1972; 5():379-92. PubMed ID: 5054209
    [No Abstract]   [Full Text] [Related]  

  • 9. Uptake of (3H)-catecholamines by homogenates of rat corpus striatum and cerebral cortex: effects of amphetamine analogues.
    Harris JE; Baldessarini RJ
    Neuropharmacology; 1973 Jul; 12(7):669-79. PubMed ID: 4730376
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the release of [3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabelled dopamine.
    Liang NY; Rutledge CO
    Biochem Pharmacol; 1982 Mar; 31(6):983-92. PubMed ID: 7082379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain.
    Nguyen TB; Angers M
    Biochem Pharmacol; 1987 May; 36(10):1731-5. PubMed ID: 3109430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychobiological foundations of behaviors induced by amphetamines.
    Groves PM; Segal DS
    NIDA Res Monogr; 1984; 54():356-66. PubMed ID: 6099879
    [No Abstract]   [Full Text] [Related]  

  • 13. Morphine and beta-endorphin inhibit release of noradrenaline from cerebral cortex but not of dopamine from rat striatum.
    Arbilla S; Langer SZ
    Nature; 1978 Feb; 271(5645):559-61. PubMed ID: 622192
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of neurohumoral and adrenergic agents on cyclic AMP levels in various areas of the rat brain in vitro.
    Palmer GC; Sulser F; Robison GA
    Neuropharmacology; 1973 Apr; 12(4):327-37. PubMed ID: 4145053
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of nomifensine on the depletion of brain serotonin and catecholamines induced respectively by fenfluramine and 6-hydroxydopamine in rats.
    Samanin R; Bernasconi S; Garattini S
    Eur J Pharmacol; 1975 Dec; 34(2):377-80. PubMed ID: 1234558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychotropic drugs and dopamine uptake inhibition.
    Halaris AE; Freedman DX
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():247-58. PubMed ID: 3829
    [No Abstract]   [Full Text] [Related]  

  • 17. Ascending catecholamine systems and morphine analgesia.
    Price MT; Fibiger HC
    Brain Res; 1975 Nov; 99(1):189-93. PubMed ID: 1188982
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of uptake of catecholamines by benzylamine derivatives.
    Kammerer RC; Amiri B; Cho AK
    J Med Chem; 1979 Apr; 22(4):352-5. PubMed ID: 430475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic binding and their effects on the spontaneous and potassium-evoked release of 3H-dopamine from the striatum and of 3H-noradrenaline from the cerebral cortex.
    Arbilla S; Briley MS; Dubocovich ML; Langer SZ
    Life Sci; 1978 Oct; 23(17-18):1775-80. PubMed ID: 31532
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative actions of monomethoxyamphetamines on the release and uptake of biogenic amines in brain tissue.
    Tseng LF; Menon MK; Loh HH
    J Pharmacol Exp Ther; 1976 May; 197(2):263-71. PubMed ID: 1271280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.